5/23
06:02 am
eprx
Eupraxia Pharmaceuticals Inc. (NASDAQ: EPRX) was upgraded by analysts at Raymond James to a "strong-buy" rating.
Medium
Report
Eupraxia Pharmaceuticals Inc. (NASDAQ: EPRX) was upgraded by analysts at Raymond James to a "strong-buy" rating.
5/23
06:02 am
eprx
Eupraxia Pharmaceuticals Inc. (NASDAQ: EPRX) was upgraded by analysts at Raymond James to a "strong-buy" rating.
Medium
Report
Eupraxia Pharmaceuticals Inc. (NASDAQ: EPRX) was upgraded by analysts at Raymond James to a "strong-buy" rating.